Name
GS1-05 - Datopotamab Deruxtecan (Dato-DXd) in Advanced/Metastatic HER2 Negative Breast Cancer: Triple Negative Breast Cancer Results from the Phase 1 TROPION-PanTumor01 Study
Date & Time
Tuesday, December 7, 2021
Speakers
Hope Rugo, MD
Hope Rugo, MD
Virtual Session Link
View Session